Article
Cervical artery dissection: pathology, epidemiology and management.
Thrombosis research - 1 Apr 2009
Kim Yang-Ki, Schulman Sam
Abstract excerpt
BACKGROUND: Cervical artery dissection is often treated with anticoagulants to prevent ischemic stroke. The risk-benefit ratio of anticoagulation versus antiplatelet therapy is unclear. OBJECTIVES: To provide an educational review of current data on the disease to explain the rationale for the treatment options and to explore the results of management studies in order to determine if anticoagulation is justified....
Topics
- Anticoagulants
- Carotid Artery, Internal, Dissection
- Humans
- Intercellular Adhesion Molecule-1
- Methylenetetrahydrofolate Reductase (NADPH2)
- Platelet Aggregation Inhibitors
- Polymorphism, Single Nucleotide
- Risk Factors
- Thromboembolism
- Thrombolytic Therapy